Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Lavanya Kondapalli to Humans

This is a "connection" page, showing publications Lavanya Kondapalli has written about Humans.

 
Connection Strength
 
 
 
0.286
 
  1. Andrade-Bucknor S, Rodriguez BPR, Ma C, Lyubarova R, Kondapalli L. Imaging in Cardio-Oncology: Role of Novel Echo Parameters in Breast Cancer and Gynecologic Malignancies. Curr Cardiol Rep. 2026 Apr 23; 28(1).
    View in: PubMed
    Score: 0.024
  2. Bast JA, Olubi O, Le DE, Parashar S, Dobrescu I, Kondapalli L. Cardiovascular Consequences of Premature Menopause. Curr Cardiol Rep. 2025 Aug 13; 27(1):126.
    View in: PubMed
    Score: 0.023
  3. Kondapalli L, Overholser L, Lenneman C. Cardiac Care of Childhood Cancer Survivors: Time to Act Instead of React. J Am Coll Cardiol. 2024 02 27; 83(8):839-842.
    View in: PubMed
    Score: 0.020
  4. Quintana RA, Ghosh AK, Kondapalli L. Mind the Gap: Differences in Acute Myocardial Infarction Care Due to a Cancer Diagnosis in England. Circ Cardiovasc Qual Outcomes. 2023 06; 16(6):e010080.
    View in: PubMed
    Score: 0.020
  5. Lenneman C, Harrison D, Davis SL, Kondapalli L. Current Practice in Carcinoid Heart Disease and Burgeoning Opportunities. Curr Treat Options Oncol. 2022 12; 23(12):1793-1803.
    View in: PubMed
    Score: 0.019
  6. Kondapalli L, Arora G, Hawi R, Andrikopoulou E, Estes C, Patel N, Lenneman CG. Innovations in Cardio-oncology Resulting from the COVID-19 Pandemic. Curr Treat Options Oncol. 2022 09; 23(9):1288-1302.
    View in: PubMed
    Score: 0.018
  7. Kondapalli L, Neilan TG. Immune checkpoint inhibitors and cardiovascular events among patients with cancer: a window into the critical role of the immune system in cardiovascular biology. Eur Heart J. 2021 12 21; 42(48):4978-4980.
    View in: PubMed
    Score: 0.018
  8. Kondapalli L, Medina T, Groves DW. Practical cardiovascular imaging approach to diagnose immune checkpoint inhibitor myocarditis. Eur Heart J Cardiovasc Imaging. 2021 03 22; 22(4):372-374.
    View in: PubMed
    Score: 0.017
  9. Kondapalli L, Bottinor W, Lenneman C. By Releasing the Brakes With Immunotherapy, Are We Accelerating Atherosclerosis? Circulation. 2020 12 15; 142(24):2312-2315.
    View in: PubMed
    Score: 0.016
  10. Kondapalli L, Moslehi J, Bonaca MP. Inflammation begets inflammation: cancer and acute MI. Eur Heart J. 2020 06 14; 41(23):2194-2196.
    View in: PubMed
    Score: 0.016
  11. Kondapalli L, Worth S, Hawi R, Vachhani P, Arora G, Bhatia R, Lenneman CG. Collaborative cardiovascular management of patients with chronic myeloid leukemia on tyrosine kinase inhibitors. Vasc Med. 2020 06; 25(3):246-254.
    View in: PubMed
    Score: 0.016
  12. Kondapalli LA, Molinaro TA, Sammel MD, Dokras A. A decrease in serum estradiol levels after human chorionic gonadotrophin administration predicts significantly lower clinical pregnancy and live birth rates in in vitro fertilization cycles. Hum Reprod. 2012 Sep; 27(9):2690-7.
    View in: PubMed
    Score: 0.009
  13. Levitzky Y, Carta KG, Kondapalli L, Davis E, Andrade-Bucknor S. Sex Differences in the Impact of Physical Activity Across the Spectrum of Cardiovascular Disease. Curr Cardiol Rep. 2026 Mar 18; 28(1).
    View in: PubMed
    Score: 0.006
  14. Kondapalli L, Soltani K, Lacouture ME. The promise of molecular targeted therapies: protein kinase inhibitors in the treatment of cutaneous malignancies. J Am Acad Dermatol. 2005 Aug; 53(2):291-302.
    View in: PubMed
    Score: 0.006
  15. Mahana I, Asturias-Gonzalez K, Mei P, Kalt M, Parashar S, Rao R, Kondapalli L, Olubi OM, Le DE. The Impact of Mental Health on Cardiovascular Disease in Women. Curr Cardiol Rep. 2025 Jul 11; 27(1):110.
    View in: PubMed
    Score: 0.006
  16. Mei P, Levitzky YS, Parashar S, Rao RA, Kondapalli L, Le DE. Current Status of Cardiovascular Disease in Asian Americans: One Size Does Not Fit All. Curr Cardiol Rep. 2025 Jun 17; 27(1):94.
    View in: PubMed
    Score: 0.006
  17. Gupta P, Canonico ME, Faaborg-Andersen C, Prabhu N, Kondapalli L, Quintana RA. Updates in the management of cancer therapy-related hypertension. Curr Opin Cardiol. 2024 Jul 01; 39(4):235-243.
    View in: PubMed
    Score: 0.005
  18. Roy S, Lakritz S, Schreiber AR, Kuna EM, Bradley CJ, Kondapalli L, Diamond JR. Major cardiovascular adverse events in older adults with early-stage triple-negative breast cancer treated with adjuvant taxane + anthracycline versus taxane-based chemotherapy regimens: A SEER-medicare study. Eur J Cancer. 2024 01; 196:113426.
    View in: PubMed
    Score: 0.005
  19. Patel M, Hudson O, Han J, Kondapalli L, Arora G, Hawi R, Andrikopoulou E, Estes C, Johnson AM, Lenneman C. Update on Immunotherapy Cardiotoxicity: Checkpoint Inhibitors, CAR T, and Beyond. Curr Treat Options Oncol. 2023 11; 24(11):1489-1503.
    View in: PubMed
    Score: 0.005
  20. Roy S, Lakritz S, Schreiber AR, Molina E, Kabos P, Wood M, Elias A, Kondapalli L, Bradley CJ, Diamond JR. Clinical outcomes of adjuvant taxane plus anthracycline versus taxane-based chemotherapy regimens in older adults with node-positive, triple-negative breast cancer: A SEER-Medicare study. Eur J Cancer. 2023 05; 185:69-82.
    View in: PubMed
    Score: 0.005
  21. Zaha VG, Hayek SS, Alexander KM, Beckie TM, Hundley WG, Kondapalli L, Ky B, Leger KJ, Meijers WC, Moslehi JJ, Shah SH. Future Perspectives of Cardiovascular Biomarker Utilization in Cancer Survivors: A Scientific Statement From the American Heart Association. Circulation. 2021 12 21; 144(25):e551-e563.
    View in: PubMed
    Score: 0.004
  22. Schreiber AR, Kagihara J, Eguchi M, Kabos P, Fisher CM, Meyer E, Molina E, Kondapalli L, Bradley CJ, Diamond JR. Evaluating anthracycline?+?taxane versus taxane-based chemotherapy in older women with node-negative triple-negative breast cancer: a SEER-Medicare study. Breast Cancer Res Treat. 2022 Jan; 191(2):389-399.
    View in: PubMed
    Score: 0.004
  23. Alvarez-Cardona JA, Ray J, Carver J, Zaha V, Cheng R, Yang E, Mitchell JD, Stockerl-Goldstein K, Kondapalli L, Dent S, Arnold A, Brown SA, Leja M, Barac A, Lenihan DJ, Herrmann J. Cardio-Oncology Education and Training: JACC Council Perspectives. J Am Coll Cardiol. 2020 11 10; 76(19):2267-2281.
    View in: PubMed
    Score: 0.004
  24. Graffagnino J, Kondapalli L, Arora G, Hawi R, Lenneman CG. Strategies to Prevent Cardiotoxicity. Curr Treat Options Oncol. 2020 04 08; 21(4):32.
    View in: PubMed
    Score: 0.004
  25. Dent SF, Kikuchi R, Kondapalli L, Ismail-Khan R, Brezden-Masley C, Barac A, Fradley M. Optimizing Cardiovascular Health in Patients With Cancer: A Practical Review of Risk Assessment, Monitoring, and Prevention of Cancer Treatment-Related Cardiovascular Toxicity. Am Soc Clin Oncol Educ Book. 2020 Mar; 40:1-15.
    View in: PubMed
    Score: 0.004
  26. Mehta LS, Watson KE, Barac A, Beckie TM, Bittner V, Cruz-Flores S, Dent S, Kondapalli L, Ky B, Okwuosa T, Piña IL, Volgman AS. Cardiovascular Disease and Breast Cancer: Where These Entities Intersect: A Scientific Statement From the American Heart Association. Circulation. 2018 02 20; 137(8):e30-e66.
    View in: PubMed
    Score: 0.003
  27. Mountantonakis SE, Elkassabany N, Kondapalli L, Marchlinski FE, Mandel JE, Hutchinson MD. Provocation of atrial fibrillation triggers during ablation: does the use of general anesthesia affect inducibility? J Cardiovasc Electrophysiol. 2015 Jan; 26(1):16-20.
    View in: PubMed
    Score: 0.003
  28. Gaztañaga L, Frankel DS, Kohari M, Kondapalli L, Zado ES, Marchlinski FE. Time to recurrence of atrial fibrillation influences outcome following catheter ablation. Heart Rhythm. 2013 Jan; 10(1):2-9.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)